Discover the truth behind “Ozempic Personality” as we explore how GLP-1 medications like Ozempic may impact mood and behavior. We’ll discuss potential mood changes, the connection between weight loss and mental health, and what the current research says.
Explore Rob’s powerful story as he battles obesity, navigates the challenges of the Standard American Diet (SAD), and finds hope through specialized care and GLP-1 medication. Learn about the complexities of managing obesity, the importance of targeted treatment, and how Rob’s journey offers valuable insights for anyone facing similar health struggles. Watch now and be inspired to take control of your health.
Ever wondered why weight-loss drugs like Wegovy cost over $1,000 a month in the US while only $25 to make? The high prices are due to more than just manufacturing costs. Discover the impact of lobbying, research expenses, and the role of Pharmacy Benefit Managers (PBMs) in this eye-opening vlog.
Watch the premiere episode of ‘Obesity Stories’ as Kendra shares her inspiring journey of losing over 100 lbs, overcoming mental health challenges, and her experiences with GLP-1 medications. Discover her lifestyle changes, struggles with loose skin, and plans for plastic surgery. Be inspired by her resilience and determination.
Should you worry about blindness from semaglutide? A recent study in JAMA Ophthalmology found a link between semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), a rare eye condition. The study compared data from individuals using semaglutide for diabetes or obesity with those who weren’t.
Discover how to use Wegovy for effective weight loss while preserving muscle mass. Learn essential strategies for long-term health, including the importance of muscle maintenance and optimal protein intake. Get practical tips and expert insights to support your weight loss journey and improve your overall well-being.
A recent study published in May 2024 unveiled a long-term outcome of Semaglutide, known as Wegovy or Ozempic. This builds on the SELECT trial, which showed Wegovy could reduce major cardiovascular events by 20% in individuals with obesity and no diabetes. Conducted by Ryan et al., the study followed participants for 208 weeks, or about four years.
Meet Orforglipron, the new oral GLP-1 agonist that could revolutionize weight loss. Unlike other treatments that require careful timing, Orforglipron can be taken anytime, making it a more convenient option. Discover how it compares to popular treatments like Wegovy, exploring its effectiveness, ease of use, and potential benefits.
Discover the groundbreaking potential of Bimagrumab, a new drug that may help you lose fat and gain muscle simultaneously. I explain the science behind Bimagrumab, its effects on obesity and muscle growth, and the promising results from recent studies. Learn about the benefits, side effects, and future implications of this innovative treatment.
Does Wegovy, also known as semaglutide or Ozempic, help or harm your kidneys? According to some “google doctors” in my comment sections, the answer is a resounding YES! But, hold on—it’s not that simple. On the flip side, exciting new research suggests Wegovy could actually protect your kidneys!
Calculate your daily calorie and protein targets to help you achieve your weight goals.
Calculate your daily calorie and protein targets to help you achieve your weight goals.
